ARVN (STOCKS)
Arvinas, Inc
$9.010000
+0.140000 (+1.58%)
Prev close: $8.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Randy Teel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $649.77M
- Employees
- 430
- P/E (TTM)
- 55.30
- P/B (TTM)
- 1.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
10
Buy
8
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$2.58 | $-0.38 | +2.9572 | +783.99% |
|
Mar 2026 (Q1)
|
$-0.90 | $-0.94 | +0.0375 | +4.00% |
|
Dec 2025 (Q4)
|
$-1.10 | $-0.60 | -0.4978 | -82.66% |
|
Sep 2025 (Q3)
|
$-0.48 | $-0.81 | +0.3298 | +40.73% |
Financial Statements
| Assets | $675.10M |
| Current Assets | $652.20M |
| Noncurrent Assets | $22.90M |
| Fixed Assets | $5.00M |
| Other Non-current Assets | $17.90M |
| Liabilities | $112.90M |
| Current Liabilities | $82.50M |
| Accounts Payable | $7.50M |
| Wages | $7.80M |
| Other Current Liabilities | $67.20M |
| Noncurrent Liabilities | $30.40M |
| Long-term Debt | $500.00K |
| Other Non-current Liabilities | $29.90M |
| Equity | $562.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $562.20M |
| Liabilities And Equity | $675.10M |